1 Seoud M,Tjalma WA,Ronsse V.Cervical adenocarcinoma:moving towards better prevention.Vaccine,2011,29:9148-9158. 2 Galic V,Herzog TJ,Lewin SN,et al.Prognostic significance of adenocarcinoma histology in women with cervical cancer.Gynecol Oncol,2012,125:287-291. 3 NCCN Guidelines Version 2,2015.Cervieal cancer http://www.nccn.org/ professionals/physician_gls/pdf/cervieal.pdf. 4 Touhami O,Plante M.Should ovaries be removed or not in (early-stage) adenocarcinoma of the uterine cervix:a review.Gynecol Oncol,2015,136:384-388. 5 Lyu J,Sun T,Tan X,et al.Ovarian preservation in young patients with stage I cervical adenocarcinoma:a surveillance,epidemiology,and end results study.Int J Gynecol Cancer,2014,24:1513-1520. 6 Meglic L,Pogacnik RK,Rakar S,et al.Clinical outcome of patients with microinvasive adenocarcinoma of the uterine cervix.Eur J Gynaecol Oncol,2013,34:296-269. 7 Sopracordevole F,Canzonieri V,Giorda G,et al.Conservative treatment of microinvasive adenocarcinoma of uterine cervix:long-term follow-up.J Low Genit Tract Dis,2012,16:381-386. 8 Al-Kalbani M,McVeigh G,McCluggage WG,et al.Do FIGO stage IA and small (≤2cm) IB1 cervical adenocarcinomas have a good prognosis and warrant less radical surgery? Int J Gynecol Cancer,2012,22:291-295. 9 Helpman L,Grisaru D,Covens A,et al.Early adenocarcinoma of the cervix:is radical vaginal trachelectomy safe? Gynecol Oncol,2011,123:95-98. 10 Kim HS,Choi CH,Lim MC,et al.Safe criteria for less radical trachelectomy in patients with early-stage cervical cancer:a multicenter clinicopathologic study.Ann Surg Oncol,2012,19:1973-1979. 11 Chen JL,Huang CY,Huang YS,et al.Differential clinical characteristics,treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.Acta Obstet Gynecol Scand,2014,93:661-668. 12 罗敏,杨佳欣,沈铿,等.局部晚期宫颈腺癌根治性放疗后辅助子宫切除术的临床分析.生殖医学杂志,2012,21:4-7. 13 闻强,方素华.宫颈腺癌早期手术治疗及预后分析.中国妇幼健康研究,2014,5:888-890. 14 Shimada M,Nishimura R,Nogawa T,et al.Comparison of the outcome between Cervical adenocarcinoma and squamous cell carcinoma patients with adjuvant radiotherapy following radical surgery:SGSG/TGCU Intergroup Surveillance.Mol Clin Oncol,2013,1:780-784. 15 Du XL,Tao J,Sheng XG,et al.Intensity-modulated radiation therapy for advanced cervical cancer:a comparison of dosimetric and clinical outcomes with conventional radiotherapy.Gynecol Oncol,2012,125:151-157. 16 王璐璐,孔为民.放疗新技术在子宫颈癌治疗中应用的进展.中华妇产科杂志,2013,48:792-794. 17 Xiong Y,Liu J,Chen S,et al.Combination of external beam radiotherapy and Californium (Cf)-252 neutron intracavity brachytherapy is more effective in controlof cervical squamous cell carcinoma than that of cervical adenocarcinoma.Med Oncol,2015,32:231. 18 Fujiwara K,Monk B,Devouassoux-Shisheboran M.Adenocarcinoma of the uterine cervix:why is it different? Curr Oncol Rep,2014,16:416. 19 Tang J,Tang Y,Yang J,et al.Chemoradiation and adjuvant chemotherapy in advanced cervical adenocarcinoma.Gynecol Oncol,2012,125:297-302. 20 郭苏阳,杨波,李群,等.术前新辅助化疗在Ⅰb2～Ⅱb期子宫颈腺癌中的应用效果观察.蚌埠医学院学报,2014,39:875-878. 21 Lorusso D,Ramondino S,Mancini M,et al.Phase II trial on cisplatin-adriamycin-paclitaxel combination as neoadjuvant chemotherapy for locally advanced cervical adenocarcinoma.Int J Gynecol Cancer,2014,24:729-734. 22 Tsubamoto H,Maeda H,Kanazawa R,et al.Phase II trial on neoadjuvant intravenous and trans-uterine arterial chemotherapy for locally advanced bulky cervical adenocarcinoma.Gynecol Oncol,2013,129:129-134. 23 李桑,谢榕,林玉珍,等.局部晚期宫颈腺癌新辅助化疗方式探讨.现代肿瘤医学,2011,19:2508-2510. 24 Li C,Ye H.Mifepristone sensitizing cisplatin for cervical adenocarcinoma HeLa cell sensitivity to chemotherapy and its mechanism.Eur J Gynaecol Oncol,2013,34:142-147. 25 欧鹏举,安煜致.贝伐珠单抗联合单药化疗治疗晚期宫颈腺癌的疗效研究.中国全科医学,2015,11:1343-1345.
